Bringing science and medicine together to help patients with cancer
European Medicines Agency (EMA) approves safety label update for Novartis Beovu
Novartis reports positive topline results from the first Phase III trial of Beovu  versus aflibercept in patients with diabetic macular edema (DME)
New collaboration between Novartis and Africa Medical Supplies Platform to facilitate supply of COVID-19 related medicines
Novartis announces ambitious ESG targets to increase access to medicines and achieve full carbon neutrality
Novartis announces positive results from Phase II study of LNP023 in patients with paroxysmal nocturnal hemoglobinuria (PNH)
The coronavirus is giving health and pharma companies a chance to woo tech talent
